PART1 and gastric cancer: By conducting data mining in RNAseq data of GC patients and thereafter determination of differentially expressed genes and calculating the AUC of the ROC curve, we identified a five-lncRNA signature (PART1, UCA1, DIRC3, HOTAIR, and HOXA11AS) as a novel potential biomarker for diagnosis of GC patients.